129 related articles for article (PubMed ID: 34219892)
21. Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma?
Paessler M; Kreisel FH; LiVolsi VA; Akslen LA; Baloch ZW
Int J Surg Pathol; 2002 Oct; 10(4):267-72. PubMed ID: 12490976
[TBL] [Abstract][Full Text] [Related]
22. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
23. Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.
Park JS; Chang JW; Liu L; Jung SN; Koo BS
Oral Oncol; 2017 Sep; 72():183-187. PubMed ID: 28222967
[TBL] [Abstract][Full Text] [Related]
24. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
[TBL] [Abstract][Full Text] [Related]
25. Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer.
Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 May; 27(5):626-631. PubMed ID: 27597378
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
[TBL] [Abstract][Full Text] [Related]
27. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
28. [Differentiated thyroid carcinoma: prognostic factors].
Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
[TBL] [Abstract][Full Text] [Related]
29. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
[TBL] [Abstract][Full Text] [Related]
30. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
Zhang Q; Wang Z; Meng X; Duh QY; Chen G
Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
[TBL] [Abstract][Full Text] [Related]
31. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
[TBL] [Abstract][Full Text] [Related]
32. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
33. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma.
Jin BJ; Kim MK; Ji YB; Song CM; Park JH; Tae K
Oral Oncol; 2015 Aug; 51(8):759-63. PubMed ID: 26093388
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography.
Lee CY; Kim SJ; Ko KR; Chung KW; Lee JH
J Ultrasound Med; 2014 Feb; 33(2):231-8. PubMed ID: 24449725
[TBL] [Abstract][Full Text] [Related]
36. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
37. Extent of surgery did not affect recurrence during 7-years follow-up in papillary thyroid cancer sized 1-4 cm: Preliminary results.
Kim MJ; Lee MC; Lee GH; Choi HS; Cho SW; Kim SJ; Lee KE; Park YJ; Park DJ
Clin Endocrinol (Oxf); 2017 Jul; 87(1):80-86. PubMed ID: 28338234
[TBL] [Abstract][Full Text] [Related]
38. Unexpected high-risk pathologic features following thyroidectomy in the chinese immigrant population.
Badhey AK; Moshier E; Jategaonkar A; Wong A; Echanique K; Chai RL
Laryngoscope; 2020 Jul; 130(7):1844-1849. PubMed ID: 31593307
[TBL] [Abstract][Full Text] [Related]
39. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
Zaman SU; Awan MS; Sulaiman MA
Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
[TBL] [Abstract][Full Text] [Related]
40. Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia.
Kahn C; Simonella L; Sywak M; Boyages S; Ung O; O'Connell D
Thyroid; 2012 Jun; 22(6):604-10. PubMed ID: 22524497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
